BACKGROUND To handle the increasing complexity of congestive heart failure (CHF) care, several new models for the care of patients with CHF have been developed to replace traditional strategies. We undertook this study to evaluate the potential benefit of implementing a CHF disease management program at a tertiary care center, particularly in terms of beta-blocker use and cost to the health car...

UNLABELLED objectives; The aim of this study was to determine whether in patients with congestive heart failure (CHF) a distensibility (Dist) reduction: 1) similarly occurs in different arteries; 2) is related to CHF severity; and 3) is reversible with treatment. background: Several studies suggest that CHF is accompanied by a reduced arterial Dist. METHODS We measured diameter in radial arte...

Abstract Heart failure is a clinical syndrome with considerable morbidity and mortality rates. Recent data published by National Health Nutrition Examination Survey (NHANES) showed that 6 million Americans are diagnosed CHF. The prevalence of CHF expected to increase 46% from 2012 2030. current therapy for acute exacerbation involves the use oral or intravenous diuretics. Aquapheresis form slow...

Health technology A comprehensive multidisciplinary care programme for patients hospitalised with congestive heart failure (CHF). The programme was designed according to the guidelines of the Agency for Health Care Policy and Research (AHCPR) and consisted of intensive patient and family education on diet, compliance and symptom recognition. The programme also included outpatient infusion of in...

The mechanism of the increased stiffness of peripheral vessels in patients with congestive heart failure (CHF) is unknown. It was considered that an increased sodium (Na+) content of peripheral vessels, shown in experimental CHF, might lead to diminished arteriolar dilator capacity. Thus, Na+ retention was induced in six normal volunteers by the daily oral administration of 0.2 mg of fludrocort...

Clinical congestive heart failure (CHF) is a major risk factor for strokes. Patients with CHF commonly have atrial fibrillation or flutter (AF), which is frequently associated with, may be a marker for, and may be the mechanism of, ischemic strokes. To determine whether stroke patients with CHF have a high incidence of AF (that may be intermittent and not diagnosed), we reviewed all the 12 lead...

Congestive Heart Failure (CHF) is one of the most prevalent public health problem of today. CHF is not a disease but a condition that occurs when the heart is unable to pump enough blood to meet the needs of body’s tissues. Deficient myocardial Carnitine levels are also involved in the pathogenesis of CHF. Various inotropic drugs, diuretics and vasodilators used in treatment improved the condit...

BACKGROUND Congestive heart failure (CHF) is a common cardiovascular disease that is often accompanied by ventricular arrhythmias. The decrease of the slow component of the delayed rectifier potassium current (IKs) in CHF leads to action potential (AP) prolongation, and the IKs is an important contributor to the development of ventricular arrhythmias. However, the molecular mechanisms underlyin...

We compared the cardiac inotropic, lusitropic, and chronotropic responses to the Na(+) channel enhancer LY-368052 in conscious dogs before and after development of congestive heart failure (CHF). We also examined the effect of LY-368052 on baroreflex sensitivity and the efferent neural mechanisms of the bradycardic response in heart failure. Dogs were chronically instrumented, and heart failure...